相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Circular RNA circPPP6R3 upregulates CD44 to promote the progression of clear cell renal cell carcinoma via sponging miR-1238-3p
Zhiliang Chen et al.
CELL DEATH & DISEASE (2022)
Loss of STAT5A promotes glucose metabolism and tumor growth through miRNA-23a-AKT signaling in hepatocellular carcinoma
Yabo Jiang et al.
MOLECULAR ONCOLOGY (2021)
Global Burden of 5 Major Types of Gastrointestinal Cancer
Melina Arnold et al.
GASTROENTEROLOGY (2020)
Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells
Karina E. Gomez et al.
CANCER RESEARCH (2020)
CD44+ cytokeratin-positive tumor cells in blood and bone marrow are associated with poor prognosis of patients with gastric cancer
Antoni Szczepanik et al.
GASTRIC CANCER (2019)
Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology
Carlota Recio et al.
ONCOGENE (2019)
FNDC3B circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E-cadherin and CD44 expression
Yuling Hong et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Expression of DEC2 enhances chemosensitivity by inhibiting STAT5A in gastric cancer
Hongyu Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition
Keiichiro Sakuma et al.
GUT (2018)
CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis
Niklas Mueller et al.
BLOOD (2018)
The biology and role of CD44 in cancer progression: therapeutic implications
Chen Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Stem cell fate in cancer growth, progression and therapy resistance
Nikki K. Lytle et al.
NATURE REVIEWS CANCER (2018)
Resistance to HSP90 inhibition involving loss of MCL1 addiction
S. Busacca et al.
ONCOGENE (2016)
CD44: More than a mere stem cell marker
I. Morath et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer
Pooja G. Talati et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Different Levels of Twist1 Regulate Skin Tumor Initiation, Stemness, and Progression
Benjamin Beck et al.
CELL STEM CELL (2015)
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Xin Ye et al.
NATURE (2015)
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
Yongmin Yan et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
Matilde Todaro et al.
CELL STEM CELL (2014)
Calreticulin Promotes Migration and Invasion of Esophageal Cancer Cells by Upregulating Neuropilin-1 Expression via STAT5A
Feng Shi et al.
CLINICAL CANCER RESEARCH (2014)
STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
K. A. Dorritie et al.
LEUKEMIA (2014)
Therapeutic modulators of STAT signalling for human diseases
Gabriella Miklossy et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous Carcinoma
Banibrata Sen et al.
CLINICAL CANCER RESEARCH (2012)
STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease
Geqiang Li et al.
BLOOD (2010)
Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo
Ayush Dagvadorj et al.
CLINICAL CANCER RESEARCH (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)